<DOC>
	<DOCNO>NCT00433602</DOCNO>
	<brief_summary>RATIONALE : Chemotherapy may cause blood clot form thigh , leg , lung . This study may help doctor understand often blood clot occur patient undergoing chemotherapy . PURPOSE : This clinical trial study often blood clot occur patient undergo chemotherapy solid tumor , include colorectal cancer , stomach cancer , lung cancer , ovarian cancer , pancreatic cancer , prostate cancer , metastatic breast cancer</brief_summary>
	<brief_title>Incidence Blood Clots Patients Undergoing Chemotherapy Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : - Determine incidence venous thromboembolic event ( i.e. , deep vein thrombosis and/or pulmonary embolism ) patient undergo chemotherapy solid tumor . OUTLINE : This prospective , multicenter survey . Patients undergo observation begin day 1 chemotherapy continue 3 month absence symptomatic , confirmed deep vein thrombosis pulmonary embolism ; use anticoagulant therapy 5 day curative treatment ; initiation thromboprophylaxis reason . Patients undergo bilateral compression ultrasound low limb baseline 3 month ( earlier timepoint , indicate ) . PROJECTED ACCRUAL : A total 2,000 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Cytologically histologically confirm diagnosis 1 following : Metastatic breast cancer Colorectal cancer Gastric cancer Lung cancer Ovarian cancer Pancreatic cancer Hormonerefractory prostate cancer Scheduled undergo chemotherapy ≥ 3 month Chemotherapy colorectal , gastric , lung , ovarian , pancreatic cancer may administer neoadjuvant , adjuvant , palliative set History deep vein thrombosis pulmonary embolism allow treatment secondary prevention last episode complete prior study entry Negative baseline bilateral compression ultrasonography PATIENT CHARACTERISTICS : Life expectancy &gt; 3 month PRIOR CONCURRENT THERAPY : See Disease Characteristics More 6 week since prior chemotherapy* Hormonal therapy alone consider chemotherapy More 4 week since prior major surgery , include surgery cancer Minor surgery ( e.g. , implant portacath ) within past 4 week allow No concurrent major surgery , include surgery cancer , observation period Radiotherapy observation period allow Concurrent chemotherapy* combination additional hormonal therapy allow Concurrent treatment ( exception antithrombotic therapy ) clinical trial allow No concurrent schedule use thromboprophylaxis anticoagulant therapy , include follow : Parenteral anticoagulant ( e.g. , heparin , low molecularweight heparin , agent , fondaparinux bivalirudin ) Oral anticoagulant ( e.g. , vitamin K antagonist ) Thrombolytic agent Chronic treatment antiplatelet agent , lowdose aspirin ( ≤ 300 mg/day ) clopidogrel allow NOTE : *Chemotherapy define treatment antineoplastic agent , include biologicals</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>thromboembolism</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>stage I colon cancer</keyword>
	<keyword>stage II colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>stage I rectal cancer</keyword>
	<keyword>stage II rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent gastric cancer</keyword>
	<keyword>stage I gastric cancer</keyword>
	<keyword>stage II gastric cancer</keyword>
	<keyword>stage III gastric cancer</keyword>
	<keyword>stage IV gastric cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>stage II non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>stage I ovarian epithelial cancer</keyword>
	<keyword>stage II ovarian epithelial cancer</keyword>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>recurrent ovarian germ cell tumor</keyword>
	<keyword>stage I ovarian germ cell tumor</keyword>
	<keyword>stage II ovarian germ cell tumor</keyword>
	<keyword>stage III ovarian germ cell tumor</keyword>
	<keyword>stage IV ovarian germ cell tumor</keyword>
	<keyword>ovarian sarcoma</keyword>
	<keyword>ovarian stromal cancer</keyword>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>stage I pancreatic cancer</keyword>
	<keyword>stage II pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>limited stage small cell lung cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>male breast cancer</keyword>
</DOC>